Vertiv Holdings Co

VRT remains in a Stage 4 decline with a clear sequence of lower highs and lower lows, trading below declining 9, 21, and 50 EMAs. Medium-term bearish bias persists, reinforced by the downtrend structure and lack of sustained recovery. Short-term price is extreme oversold and extended beneath EMAs, making immediate selling unfavorable. Execution should be deferred and trimming into relief rallies near EMA resistance or prior structural zones preferred. Key risks include potential reversal bounces from exhaustion and support holding at the 200 DMA.

• ↑Q1 revenue of $2.65B (+30% YoY) and EPS of $1.17 (+83% YoY) beat estimates
• ↑Full-year EPS guidance lifted to $6.30–$6.40, reflecting strong operational momentum
• ↓Negative earnings yield and low book-to-price ratios raise overvaluation concerns